BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$60.22

Market cap

$8.99B

P/E Ratio

32.2

Dividend/share

$0.17

EPS

$1.87

Enterprise value

$9.39B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's EPS is up by 41% year-on-year and by 2.2% since the previous quarter
The net income is up by 38% year-on-year
Bruker's debt has increased by 48% YoY but it has decreased by 9% from the previous quarter
The quick ratio has increased by 32% YoY but it has decreased by 11% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bruker.com
Peers: PKI TMO WAT BIO

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
149.26M
Market cap
$8.99B
Enterprise value
$9.39B
Valuations
Price to earnings (P/E)
32.2
Price to book (P/B)
8.93
Price to sales (P/S)
3.68
EV/EBIT
23.51
EV/EBITDA
19.24
EV/Sales
3.82
Earnings
Revenue
$2.46B
EBIT
$399.4M
EBITDA
$487.9M
Free cash flow
$192.3M
Per share
EPS
$1.87
Free cash flow per share
$1.28
Book value per share
$6.75
Revenue per share
$16.34
TBVPS
$19.54
Balance sheet
Total assets
$3.55B
Total liabilities
$2.52B
Debt
$1.22B
Equity
$1.02B
Working capital
$1.37B
Liquidity
Debt to equity
1.2
Current ratio
2.56
Quick ratio
1.51
Net debt/EBITDA
0.82
Margins
EBITDA margin
19.8%
Gross margin
50.3%
Net margin
11.5%
Operating margin
17.1%
Efficiency
Return on assets
8.4%
Return on equity
27.1%
Return on invested capital
18.5%
Return on capital employed
15%
Return on sales
16.2%
Dividend
Dividend yield
0.28%
DPS
$0.17
Payout ratio
9.1%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
-0.64%
1 week
0.02%
1 month
-3.56%
1 year
-12.78%
YTD
-28.23%
QTD
-6.35%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$2.46B
Gross profit
$1.24B
Operating income
$420.7M
Net income
$282M
Gross margin
50.3%
Net margin
11.5%
The net income is up by 38% year-on-year
BRKR's operating income is up by 31% year-on-year
BRKR's gross profit is up by 21% year-on-year and by 2.3% since the previous quarter
Bruker's net margin has increased by 20% YoY

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
32.2
P/B
8.93
P/S
3.68
EV/EBIT
23.51
EV/EBITDA
19.24
EV/Sales
3.82
BRKR's EPS is up by 41% year-on-year and by 2.2% since the previous quarter
BRKR's price to earnings (P/E) is 26% lower than its last 4 quarters average of 43.3 and 24% lower than its 5-year quarterly average of 42.2
The stock's price to book (P/B) is 19% less than its last 4 quarters average of 11.0 but 13% more than its 5-year quarterly average of 7.9
BRKR's equity is up by 5% YoY but it is down by 5% QoQ
The stock's price to sales (P/S) is 23% less than its last 4 quarters average of 4.8 but 5% more than its 5-year quarterly average of 3.5
Bruker's revenue has increased by 16% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on equity has increased by 25% YoY
BRKR's return on assets is up by 22% year-on-year but it is down by 2.3% since the previous quarter
Bruker's return on invested capital has increased by 17% YoY but it has decreased by 7% QoQ
BRKR's return on sales is up by 17% year-on-year

Dividends

What is BRKR's dividend history
Dividend details
DPS
$0.17
Dividend yield
0.28%
Payout ratio
9.1%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 41% greater than its total liabilities
The quick ratio has increased by 32% YoY but it has decreased by 11% from the previous quarter
BRKR's current ratio is up by 24% year-on-year but it is down by 2.7% since the previous quarter
Bruker's debt is 20% more than its equity
Bruker's debt has increased by 48% YoY but it has decreased by 9% from the previous quarter
BRKR's debt to equity is up by 41% year-on-year but it is down by 4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.